ビジビリティスコア
100/100
AI言及数
1.5K
AI検索ボリューム
469.8K
2026年2月17日現在、IQVIA(iqvia.com)のAIビジビリティスコアは 100中100(Google AI OverviewやChatGPTなどのプラットフォーム全体でのAI言及数合計1.5K件に基づく)となっています。同ブランドは469.8KのAI検索ボリュームを創出しています。 従来のSEO面において、IQVIAは推定で月間214.7K件のオーガニック訪問を獲得しており、トラフィック価値は$1.3Mに相当します。 ライフサイエンス分野の競合他社と比較して、IQVIAはAI言及のシェア・オブ・ボイス(SoV)で5社中第1位に位置しています。
IQVIA is a leading contract research organization (CRO) and healthcare data analytics company formed from the merger of IMS Health and Quintiles. It provides clinical trial management, real-world evidence analytics, commercial consulting, and technology solutions to pharmaceutical and biotech companies worldwide.
IQVIAは、トラッキング対象の2個のプラットフォーム全体で合計1.5K件のAI言及を獲得しており、469.8KのAI検索ボリュームを創出しています。 Google AI Overviewが言及数の94%を占め、最大のシェアを記録しています。 AIプラットフォームはIQVIAを、IQVIA, 2025 ASCO Annual Meeting, Apple Watch Series 9を含む20個のブランドエンティティに関連付けています。
AIプラットフォームが回答内でIQVIAを引用している質問のサンプル。
IQVIA is a multinational company providing advanced analytics, technology solutions, and clinical research services to the life sciences and healthcare industries . It was formed in 2016 through the merger of Quintiles (a clinical research organization) and IMS Health (a healthcare data and analytics provider). The company offers a wide range of services, including clinical trial management, commercial insights, and technology solutions, and is headquartered in Durham, North Carolina.
Core services
Key aspects
Medtech, short for Medical Technology, is a field focused on using technology, products, and services to improve patient diagnosis, monitoring, treatment, and care.It encompasses a wide range of innovations, from simple tools like syringes and bandages to complex machinery like MRI scanners and robotic surgical systems.Medtech solutions are primarily used by healthcare professionals and are crucial for advancing healthcare systems and enhancing patient outcomes globally.
What Medtech Involves
Key Aspects of the Medtech Industry
Colon cancer treatment aims to remove the tumor, prevent its recurrence, and improve patient outcomes.The specific treatment plan depends on factors such as the stage of cancer, patient health, and tumor characteristics.123456
Common Treatment Options:
Additional Treatments:
Treatment Combinations:1
Often, multiple treatment options are combined to achieve the best results.For example, surgery may be followed by chemotherapy and radiation therapy.12
Clinical Trials:1
New and experimental treatments are constantly being evaluated through clinical trials.Patients may be eligible to participate in these trials to access cutting-edge therapies.12
Follow-Up Care:1
Regular monitoring and follow-up exams are crucial after colon cancer treatment to detect any recurrence or complications.This may include blood tests, imaging studies, and colonoscopies.12345
Note: The specific treatment plan and prognosis for each patient will vary.It's essential to consult with a qualified healthcare professional for personalized medical advice.1
"IRT " is an acronym with several different meanings depending on the context. Common interpretations include:
FDCS most commonly refers to Follicular Dendritic Cell Sarcoma , a rare cancer of immune cells, but can also stand for Fixed-Dose Combinations in medicine (multiple drugs in one pill), or even Fire Department Connection, the hookup for firefighters to boost water supply in buildings.The specific meaning depends heavily on context, but the medical/cancer definition (FDCS) is prominent due to the disease's complexity and rarity.
Medical & Biological Meanings:
Other Meanings:
To get the most relevant information, try searching with more context (e.g., "FDCS cancer," "FDC drugs," or "FDC fire").
IQVIAは45.3K個のオーガニックキーワードでランクインしており、月間推定214.7K件の訪問を獲得し、そのトラフィック価値は$1.3Mに達しています。 トラッキング期間中、オーガニックトラフィックは728.6Kから579.9Kへと減少しました。 上位ランクインキーワードには「paediatric investigation plan」(順位:4位), 「complement dependent cytotoxicity」(順位:27位), 「complement-dependent cytotoxicity」(順位:28位)などが含まれます。
オーガニックトラフィック
214.7K
月間推定訪問数
オーガニックキーワード
45.3K
ランクインキーワード
トラフィック価値
$1.3M
月間推定価値
| キーワード | 順位 | 検索ボリューム |
|---|---|---|
| paediatric investigation plan | 4 | 550.0K |
| complement dependent cytotoxicity | 27 | 301.0K |
| complement-dependent cytotoxicity | 28 | 301.0K |
| health information and management | 73 | 301.0K |
| health information managers | 95 | 301.0K |
| cells | 96 | 201.0K |
| ai assistant | 32 | 135.0K |
| artificial intelligence assistant | 46 | 135.0K |
| good clinical practice | 62 | 135.0K |
| imos | 99 | 135.0K |
| liaisoning | 93 | 135.0K |
| jobs in admin assistant | 67 | 110.0K |
| agentic.ai | 93 | 90.5K |
| country bn | 62 | 90.5K |
| ims tickets | 73 | 90.5K |
| software engineer | 25 | 90.5K |
| transparent lab | 90 | 90.5K |
| assays | 55 | 74.0K |
| clinical information systems | 15 | 74.0K |
| hospital engagement network | 64 | 74.0K |
IQVIAは、競合5社の中でAI言及のシェア・オブ・ボイス第1位となっており、全言及数の48%を獲得しています。 追跡対象の競合企業にはICON plc, PPD, Syneos Health, Medpaceが含まれます。
| 企業 | 言及数 | AIボリューム |
|---|---|---|
| iqvia.com (自社) | 1.4K | 467.0K |
| iconplc.com (ICON plc) | 727 | 308.2K |
| syneoshealth.com (Syneos Health) | 183 | 91.1K |
| ppd.com (PPD) | 485 | 194.8K |
| medpace.com (Medpace) | 102 | 31.5K |
これは静的なスナップショットです。継続的なAI可視化モニタリング、競合ベンチマーキング、そして引用フットプリントを向上させる根拠に基づいたGEOコンテンツは、VayoMedのDone-for-You成長エンジンに含まれています。